| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |